Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.38 |
| ▸ | FNTA | P49354 | 2/20 | 0.38 |
| ▸ | FNTB | P49356 | 2/20 | 0.38 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3169676 | 1.00 | ALDH1A1 (0.66) | ALDH1A1ALOX15PTPN1LMNAHSD17B10 | |
| SCHEMBL9953013 | 1.00 | ALDH1A1 (0.66) | ALDH1A1ALOX15PTPN1LMNAHSD17B10 | |
| SCHEMBL9609320 | 0.92 | ALDH1A1 (0.73) | ALDH1A1ALOX15PTPN1TRPV1FNTA | |
| SCHEMBL5150363 | 0.88 | ALDH1A1 (0.61) | ALDH1A1ALOX15PTPN1LMNAHSD17B10 | |
| SCHEMBL5150357 | 0.88 | ALDH1A1 (0.61) | ALDH1A1ALOX15PTPN1LMNAHSD17B10 | |
| SCHEMBL5152477 | 0.83 | ALDH1A1 (0.47) | ALDH1A1ALOX15PTPN1TRPV1FNTA | |
| SCHEMBL5152482 | 0.83 | ALDH1A1 (0.47) | ALDH1A1ALOX15PTPN1TRPV1FNTA | |
| SCHEMBL23036813 | 0.83 | ALDH1A1 (0.66) | ALDH1A1ALOX15PTPN1LMNAHSD17B10 | |
| SCHEMBL23036807 | 0.83 | ALDH1A1 (0.66) | ALDH1A1ALOX15PTPN1LMNAHSD17B10 | |
| SCHEMBL21518288 | 0.83 | ALDH1A1 (0.66) | ALDH1A1ALOX15PTPN1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| EP-2773430-B1 | PERFUMING COMPOSITIONS AND USES THEREOF | FIRMENICH & CIE (CH) | 2019-10-09 | — | — | EP | claimed |
| EP-2771071-B1 | PERFUMING COMPOSITIONS AND USES THEREOF | FIRMENICH & CIE (CH) | 2019-08-07 | — | — | EP | claimed |
| CN-104125847-B | Perfume composition and application thereof | 弗门尼舍有限公司 | 2017-09-08 | — | — | CN | claimed |
| US-9428712-B2 | Perfuming compositions and uses thereof | FIRMENICH SA (CH) | 2016-08-30 | — | — | US | claimed |
| CN-104114147-B | Perfume composition and uses thereof | FIRMENICH S.A. (CH) | 2016-04-13 | — | — | CN | claimed |
| US-9296978-B2 | Perfuming compositions and uses thereof | FIRMENICH SA (CH) | 2016-03-29 | — | — | US | claimed |
| CN-102933193-B | Perfuming composition and use thereof | FIRMENICH & CIE | 2015-06-17 | — | — | CN | claimed |
| US-8822404-B2 | Perfuming compositions and uses thereof | FIRMENICH SA (CH) | 2014-09-02 | — | — | US | claimed |
| EP-1188433-B1 | Use of unsaturated esters as perfuming ingredients | FIRMENICH & CIE (CH) | 2007-01-03 | — | — | EP | claimed |
| US-6924262-B2 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2005-08-02 | — | — | US | claimed |
| US-20020055455-A1 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2002-05-09 | — | — | US | claimed |
| EP-1188433-A2 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2002-03-20 | — | — | EP | claimed |
| CN-122028974-A | Ribonucleic acid-based microcapsules | 弗门尼舍有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12624309-B2 | Enol ether properfume | FIRMENICH SA (CH) | 2026-05-12 | — | — | US | disclosed |
| US-12616948-B2 | Polyamide microcapsules | FIRMENICH SA (CH) | 2026-05-05 | — | — | US | disclosed |
| US-6924262-B2 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2005-08-02 | — | — | US | disclosed |
| US-20020055455-A1 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2002-05-09 | — | — | US | disclosed |
| EP-1188433-A2 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2002-03-20 | — | — | EP | disclosed |
| US-3949007-A | METAL HYDROXIDE OR ALKOXIDE CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055455-A1 | Use of unsaturated esters as perfuming ingredients | CYP2E1, ELOVL1, ELOVL5 | ALDH1A1 744/4885ALOX15 21/4885PTPN1 4765/4885 |
| US-12616948-B2 | Polyamide microcapsules | HDHD5, DDC, USP39 | ALDH1A1 4007/4885ALOX15 3255/4885PTPN1 2679/4885 |
| US-12624309-B2 | Enol ether properfume | CYP2E1, CBR1, ADH5 | ALDH1A1 33/4885ALOX15 139/4885PTPN1 4255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.